American Century Companies Inc. Cuts Stock Holdings in Mettler-Toledo International, Inc. $MTD

American Century Companies Inc. reduced its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 45.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 47,716 shares of the medical instruments supplier’s stock after selling 39,795 shares during the quarter. American Century Companies Inc. owned approximately 0.23% of Mettler-Toledo International worth $58,577,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Huntington National Bank grew its stake in shares of Mettler-Toledo International by 47.5% in the 3rd quarter. Huntington National Bank now owns 90 shares of the medical instruments supplier’s stock worth $110,000 after acquiring an additional 29 shares in the last quarter. Quantbot Technologies LP purchased a new position in Mettler-Toledo International during the third quarter worth about $49,000. Handelsbanken Fonder AB grew its position in Mettler-Toledo International by 0.7% in the 3rd quarter. Handelsbanken Fonder AB now owns 13,749 shares of the medical instruments supplier’s stock worth $16,878,000 after purchasing an additional 91 shares in the last quarter. Andra AP fonden increased its stake in Mettler-Toledo International by 57.3% in the 3rd quarter. Andra AP fonden now owns 21,500 shares of the medical instruments supplier’s stock valued at $26,394,000 after buying an additional 7,831 shares during the last quarter. Finally, DNB Asset Management AS lifted its position in shares of Mettler-Toledo International by 0.4% during the 3rd quarter. DNB Asset Management AS now owns 4,168 shares of the medical instruments supplier’s stock worth $5,117,000 after buying an additional 17 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Insider Activity at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the completion of the transaction, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,262.96 on Friday. The stock has a market capitalization of $25.68 billion, a PE ratio of 29.98, a P/E/G ratio of 2.70 and a beta of 1.43. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,525.17. The business’s fifty day moving average price is $1,402.43 and its 200-day moving average price is $1,371.97.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. The business had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the business posted $12.41 EPS. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analysts Set New Price Targets

MTD has been the subject of several recent analyst reports. Morgan Stanley reduced their target price on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a report on Tuesday, February 10th. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Bank of America raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price for the company in a research report on Monday, December 15th. Citigroup lifted their target price on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. Finally, Wells Fargo & Company increased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $1,435.42.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.